Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPO-STROKE1: Safety of Propylthiouracil, Riociguat, and Perphenazine in Healthy Volunteers
NCT04776499Phase 1Completed
- Sponsor
- Maastricht University
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of propylthiouracil, riociguat and Perphenazine in ischemic stroke, sponsored by Maastricht University. Primary endpoint: Change of blood pressure in supine position at 4 hours. Started Mar 2021; status: completed.
02
Drugs
propylthiouracilriociguatPerphenazine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04776499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776499.